Niclosamide reduces glucagon sensitivity via hepatic PKA inhibition in obese mice: Implications for glucose metabolism improvements in type 2 diabetes
about
Carbonic anhydrase III (Car3) is not required for fatty acid synthesis and does not protect against high-fat diet induced obesity in mice.Niclosamide enhances the cytotoxic effect of cisplatin in cisplatin-resistant human lung cancer cells via suppression of lung resistance-related protein and c-myc.
P2860
Niclosamide reduces glucagon sensitivity via hepatic PKA inhibition in obese mice: Implications for glucose metabolism improvements in type 2 diabetes
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Niclosamide reduces glucagon s ...... mprovements in type 2 diabetes
@ast
Niclosamide reduces glucagon s ...... mprovements in type 2 diabetes
@en
Niclosamide reduces glucagon s ...... mprovements in type 2 diabetes
@nl
type
label
Niclosamide reduces glucagon s ...... mprovements in type 2 diabetes
@ast
Niclosamide reduces glucagon s ...... mprovements in type 2 diabetes
@en
Niclosamide reduces glucagon s ...... mprovements in type 2 diabetes
@nl
prefLabel
Niclosamide reduces glucagon s ...... mprovements in type 2 diabetes
@ast
Niclosamide reduces glucagon s ...... mprovements in type 2 diabetes
@en
Niclosamide reduces glucagon s ...... mprovements in type 2 diabetes
@nl
P2093
P2860
P50
P356
P1433
P1476
Niclosamide reduces glucagon s ...... mprovements in type 2 diabetes
@en
P2093
Abhirup Das
Greg C Smith
Lindsay E Wu
Md Kamrul Hasan Chowdhury
Nicholas L Bentley
Peter R Shepherd
Sonia Bustamante
P2860
P2888
P356
10.1038/SREP40159
P407
P577
2017-01-05T00:00:00Z
P6179
1015252543